SCHIRINZI, TOMMASO
 Distribuzione geografica
Continente #
NA - Nord America 15.816
AS - Asia 3.589
EU - Europa 2.634
Continente sconosciuto - Info sul continente non disponibili 576
SA - Sud America 547
AF - Africa 64
OC - Oceania 8
Totale 23.234
Nazione #
US - Stati Uniti d'America 15.633
SG - Singapore 1.634
IT - Italia 1.037
CN - Cina 570
BR - Brasile 434
RU - Federazione Russa 363
HK - Hong Kong 335
VN - Vietnam 280
BD - Bangladesh 218
IE - Irlanda 211
DE - Germania 187
KR - Corea 185
UA - Ucraina 134
GB - Regno Unito 131
FR - Francia 124
JP - Giappone 117
CA - Canada 100
NL - Olanda 100
SE - Svezia 83
FI - Finlandia 79
IN - India 66
PL - Polonia 48
AR - Argentina 44
MX - Messico 42
ID - Indonesia 35
AT - Austria 34
ZA - Sudafrica 29
TR - Turchia 21
IQ - Iraq 20
EC - Ecuador 19
ES - Italia 18
CO - Colombia 16
JO - Giordania 16
AL - Albania 10
CH - Svizzera 10
BE - Belgio 9
JM - Giamaica 9
KG - Kirghizistan 9
MY - Malesia 9
VE - Venezuela 9
LT - Lituania 8
MA - Marocco 8
PK - Pakistan 8
PT - Portogallo 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
CR - Costa Rica 7
PH - Filippine 7
TH - Thailandia 7
AU - Australia 6
CL - Cile 6
CZ - Repubblica Ceca 6
KE - Kenya 6
DO - Repubblica Dominicana 5
EG - Egitto 5
HR - Croazia 5
IR - Iran 5
PE - Perù 5
PY - Paraguay 5
RS - Serbia 5
TN - Tunisia 5
UY - Uruguay 5
DK - Danimarca 4
EU - Europa 4
GR - Grecia 4
IL - Israele 4
NP - Nepal 4
AZ - Azerbaigian 3
BO - Bolivia 3
HN - Honduras 3
NI - Nicaragua 3
NO - Norvegia 3
PS - Palestinian Territory 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
GE - Georgia 2
LC - Santa Lucia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
RO - Romania 2
SC - Seychelles 2
SI - Slovenia 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
BM - Bermuda 1
BS - Bahamas 1
BY - Bielorussia 1
DZ - Algeria 1
GA - Gabon 1
GT - Guatemala 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
ME - Montenegro 1
MK - Macedonia 1
Totale 22.651
Città #
Wilmington 3.524
Houston 3.127
Woodbridge 2.641
Singapore 893
San Jose 609
Ashburn 536
Fairfield 535
Chandler 363
Hong Kong 332
Council Bluffs 294
Rome 285
Ann Arbor 231
Seattle 230
Beijing 200
Cambridge 188
New York 187
Dublin 184
Santa Clara 156
The Dalles 131
Dallas 130
Medford 129
Los Angeles 123
Tokyo 114
Dearborn 110
Jacksonville 94
Milan 94
Hanoi 86
Ho Chi Minh City 86
Buffalo 68
Lawrence 61
North Bergen 59
Lauterbourg 58
São Paulo 47
Menlo Park 45
Moscow 42
Helsinki 39
Munich 37
Chicago 35
Orem 32
Toronto 31
Brooklyn 30
London 29
Nuremberg 28
Montreal 27
Phoenix 25
Warsaw 25
Redondo Beach 24
Johannesburg 21
Mexico City 21
San Diego 21
Naples 20
Stockholm 20
Boardman 19
Chennai 19
Denver 19
Frankfurt am Main 19
Kraków 18
Zhengzhou 18
Shanghai 17
Shenzhen 17
Amsterdam 16
Nanjing 16
Amman 15
Atlanta 15
Bologna 15
Boston 15
Colorado Springs 15
Jakarta 15
Norwalk 15
Seoul 15
Florence 14
Kunming 14
Lappeenranta 14
Manchester 14
Rio de Janeiro 14
Poplar 13
Bari 12
Del Norte 12
Detroit 12
Hefei 12
Monmouth Junction 12
Verona 12
Vienna 12
Columbus 11
Durham 11
Incheon 11
Miami 11
Philadelphia 11
Salt Lake City 11
Catania 10
Creede 10
Da Nang 10
Guangzhou 10
Mountain View 10
Paris 10
Belo Horizonte 9
Newham 9
Palermo 9
Salvador 9
Brussels 8
Totale 17.092
Nome #
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt-Jakob disease 630
Early synaptic dysfunction in Parkinson's disease: Insights from animal models 517
Aberrant striatal synaptic plasticity in monogenic parkinsonisms 494
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain 490
Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia 486
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 462
Occurrence of Writing Tremor in Patients With Scans Without Evidence of Dopaminergic Deficit 451
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease. 450
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice 444
Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD) 442
Centrality of striatal cholinergic transmission in Basal Ganglia function 440
PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity 438
Impaired intracortical transmission in G2019S leucine rich-repeat kinase Parkinson patients 438
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 436
CSF biomarkers in superficial siderosis: a new tool for diagnosis and evaluation of therapeutic efficacy of deferiprone--a case report 430
Double hit mouse model of Parkinson's disease 428
Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission. 414
Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia 408
Outlining a population "at risk" of Parkinson's disease: Evidence from a case-control study 405
Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence 382
Centrality of early synaptopathy in Parkinson's disease 380
Transient parkinsonism after unilateral midbrain stroke: a compensatory intervention from the healthy side? 373
Dopaminergic involvement in a drummer with focal dystonia: A case study 331
Cerebrospinal fluid biomarkers profile of idiopathic normal pressure hydrocephalus 326
Promising rodent models in Parkinson's disease 321
Assessment of serum uric acid as risk factor for tauopathies 311
Continuous dopaminergic stimulation in a patient treated with daytime Levodopa-carbidopa intestinal gel and overnight Rotigotine: a case report 311
Association between physical activity and dementia’s risk factors in patients with Parkinson’s disease 303
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease 289
Comments on: “Complementary and alternative therapies for restless legs syndrome: An evidence-based systematic review” 287
Long-term treatment with rotigotine in drug-naïve PSP patients 279
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease 273
The effect of postural deformities on back function and pain in patients with Parkinson's disease 268
Pisa Syndrome in Parkinson's Disease: Evidence for Bilateral Vestibulospinal Dysfunction 262
Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy 262
Effectiveness of robot-assisted gait training on motor impairments in people with Parkinson's disease: A systematic review and meta-analysis 261
CSF α-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients 259
Dystonia as a network disorder: A concept in evolution 245
Young-onset and late-onset Parkinson's disease exhibit a different profile of fluid biomarkers and clinical features 227
Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease 217
Assessment of Psychometric Characteristics of Parkinson’s Disease Sleep Scale 2 and Analysis of a Cut-Off Score for Detecting Insomnia in Italian Patients with Parkinson’s Disease: A Validation Study 207
Systemic activation of Nrf2 pathway in Parkinson's disease 204
Cerebrospinal fluid ferritin and siderophages in the diagnosis of superficial cerebral siderosis 204
Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease 191
Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease. 188
Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer's Disease: From Animal Models to the Human Pathology 188
A Dual Centre Study of Pain in Parkinson's Disease and Its Relationship with Other Non-Motor Symptoms 175
Technology-based assessment of motor impairment in de novo Parkinson's disease patients: implications for diagnostic accuracy and early identification of distinct phenotypes 166
Olfactory Neuron Prokineticin-2 as a Potential Target in Parkinson's Disease 161
Sex hormones differentially contribute to Parkinson disease in males: a multimodal biomarker study 156
The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia 155
The influence of postural deformities on neck function and pain in patients with Parkinson's disease 152
Transcranial Direct Current Stimolation (tDCS) on PD Patients with Freezing of Gait: Preliminary Findings 138
Adult-onset sporadic chorea: real-world data from a single-centre retrospective study 135
Spinal vascular lesions: anatomy, imaging techniques and treatment 127
Circulating calprotectin as a potential biomarker of persistent olfactory dysfunctions in Post-COVID-19 patients 123
Insular and limbic abnormal functional connectivity in early-stage Parkinson’s disease patients with autonomic dysfunction 123
Hearing dysfunction heralds an increase in non-motor burden and a worse quality of life in Parkinson’s disease: new insights from non-motor spectrum 122
Cortical functional connectivity changes in the body-first and brain-first subtypes of Parkinson's disease 120
Ischemic injury precipitates neuronal vulnerability in Parkinson{'}s disease: Insights from PINK1 mouse model study and clinical retrospective data 119
Band-Specific Altered Cortical Connectivity in Early Parkinson's Disease and its Clinical Correlates 118
Physical activity changes and correlate effects in patients with Parkinson's disease during COVID-19 lockdown 117
Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findings 116
Axial postural abnormalities and pain in Parkinson's disease 115
Sex hormones shape EEG-based functional connectivity in early-stage Parkinson’s disease patients 114
Self-reported needs of patients with Parkinson's disease during COVID-19 emergency in Italy 113
STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson's Disease 111
Clinical course of paroxysmal dyskinesias throughout pregnancy 110
COVID-19: dealing with a potential risk factor for chronic neurological disorders 106
Immunometabolic Signature and Tauopathy Markers in Blood Cells of Progressive Supranuclear Palsy 103
Technology-based therapy-response and prognostic biomarkers in a prospective study of a de novo Parkinson’s disease cohort 103
Contribution of testosterone and estradiol in sexual dimorphism of early-onset Parkinson's disease 103
Motor cortex transcranial direct current stimulation improves non-motor symptoms in early-onset Parkinson’s disease: a pilot study 102
Validation of the Italian version of the PSP Quality of Life questionnaire 102
Early Alterations in De Novo Parkinson’s Disease Revealed by Diffusion Tensor Imaging: Preliminary Study 100
Neuroimaging findings in leukoencephalopathy with calcifications and cysts: case report and review of the literature 100
Brain Functional Connectivity in de novo Parkinson's Disease Patients Based on Clinical EEG 99
Parkinson's disease motor progression in relation to the timing of REM sleep behavior disorder presentation: an exploratory retrospective study 96
Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease 95
Neutrophil-to-lymphocyte ratio and lymphocyte count reflect alterations in central neurodegeneration-associated proteins and clinical severity in Parkinson Disease patients 95
Olfactory Neuron Substance P is Overexpressed in Parkinson's Disease Reflecting Gut Dysfunction 93
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction 93
Post-COVID-19 Hyposmia Does Not Exhibit Main Neurodegeneration Markers in the Olfactory Pathway 92
Constipation distinguishes different clinical-biochemical patterns in de novo Parkinson's disease 91
Short‐Term Effects of Continuous Theta Burst Stimulation in Treating a Young Patient Affected by Post‐Ischemic Hemidystonia 91
Movement disorders in primary central nervous system lymphoma: two unreported cases and a review of literature 90
Gastrointestinal Dysfunction Bears on the Clinical‐Biological Profile of Parkinson's Disease 89
A biological characterization of patients with postmenopausal Parkinson's disease 89
Increased blood-brain barrier permeability is associated with dysfunctional α band connectivity in early-stage Parkinson’s disease 87
Exploring the Association Linking Head Position and Sleep Architecture to Motor Impairment in Parkinson’s Disease: An Exploratory Study 86
Tau and Amyloid-beta Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters 86
Stage-dependent phosphoproteome remodeling of Parkinson's disease blood cells 84
Peripheral immunity changes are associated with neurodegeneration and worse clinical outcome in idiopathic normal pressure hydrocephalus 84
Biofluids profile of ?-Klotho in patients with Parkinson{'}s disease 83
Pregnancy, fertile life factors, and associated clinical course in PRKN early-onset Parkinson’s disease 83
Pattern of Mitochondrial Respiration in Peripheral Blood Cells of Patients with Parkinson's Disease 82
Shaping the course of early-onset Parkinson’s disease: insights from a longitudinal cohort 81
Increase of Prokineticin-2 in Serum of Patients with Parkinson{'}s Disease 79
Effects of head trauma and sport participation in young-onset Parkinson?s disease 79
Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease. 74
Totale 21.858
Categoria #
all - tutte 71.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022701 0 0 60 40 6 63 143 41 38 64 72 174
2022/2023935 98 84 29 104 74 210 131 74 75 1 37 18
2023/2024532 41 14 24 12 51 113 31 71 16 52 24 83
2024/20252.790 58 505 224 146 86 279 193 227 239 292 312 229
2025/20265.449 392 191 595 426 454 207 627 637 517 634 485 284
2026/20271.079 474 344 261 0 0 0 0 0 0 0 0 0
Totale 23.234